Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer.
- DOI
- 10.1016/j.acuroe.2026.501991
- Published
- 2026 Jul-Aug
- Container
- Actas urologicas espanolas
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.acuroe.2026.501991,
title = {Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer.},
author = {Diezhandino P and Couñago F and Ocanto A and Gómez de Iturriaga A and Conde A and Maldonado X and Serrano J and López-Campos F},
year = {2026},
journal = {Actas urologicas espanolas},
doi = {10.1016/j.acuroe.2026.501991},
url = {https://doi.org/10.1016/j.acuroe.2026.501991}
}RIS
TY - JOUR TI - Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer. AU - Diezhandino P AU - Couñago F AU - Ocanto A AU - Gómez de Iturriaga A AU - Conde A AU - Maldonado X AU - Serrano J AU - López-Campos F PY - 2026 JO - Actas urologicas espanolas DO - 10.1016/j.acuroe.2026.501991 UR - https://doi.org/10.1016/j.acuroe.2026.501991 ER -
APA
P, D., F, C., A, O., A, G. D. I., A, C., X, M., J, S., & F, L. (2026). Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer.. Actas urologicas espanolas. https://doi.org/10.1016/j.acuroe.2026.501991
Source records
- pubmed · retrieved 2026-09-27T01:13:08.673Z